Alzeerelhouseini HIA, Abuzneid YS, Ashhab HA. Acute pancreatitis with giant pancreatic pseudocyst as a complication of extracorporeal shock wave lithotripsy: A case report and literature review.
Ann Med Surg (Lond) 2021;
66:102442. [PMID:
34136213 PMCID:
PMC8178083 DOI:
10.1016/j.amsu.2021.102442]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Revised: 05/19/2021] [Accepted: 05/23/2021] [Indexed: 11/29/2022] Open
Abstract
Introduction
Extracorporeal shock wave lithotripsy has been confirmed as the least invasive and the most widely used treatment for kidney and ureteral stones. However, as with any other type of therapy, potential complications do exist.
Case presentation
Herein, we describe a 55-year-old male patient who developed symptoms of acute pancreatitis one day after extracorporeal shock wave lithotripsy for left renal stones. The patient used to manage himself with NSAIDs till he presented to the emergency department with severe epigastric pain and tenderness due to giant pancreatic pseudocyst formation. The pseudocyst was treated by endoscopic cystogastrostomy using metallic stent with uneventful recovery. In addition, we extensively reviewed all available literature studies of pancreatitis and pancreatic pseudocyst occurring after extracorporeal shock wave lithotripsy. We summarized all reported cases and presented them in a comprehensive table.
Discussion
Post ESWL acute pancreatitis is a rare clinical entity with only 11 reported cases. In all cases, abdominal pain was the most common symptom that occurs in less than 24h following ESWL treatment. So it should be considered in the differential diagnosis of acute abdominal pain after ESWL.
Conclusion
Although ESWL is generally considered safe and effective treatment; however, major complications have been reported to occur in less than 1% of patients. One of the extremely rare complications is the development of pancreatitis and pancreatic pseudocyst.
ESWL is a safe and effective treatment modality.
Serious complications have been reported in 1% of patients.
Post-ESWL acute pancreatitis is extremely rare.
Only 5 cases of pancreatic pseudocyst after ESWL have been reported.
Endoscopic cystogastrostomy approach is cost-saving, can avoid surgical complications, and offer an early hospital discharge.
Collapse